These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11372729)

  • 1. Wilms' tumor gene WT1: its oncogenic function and clinical application.
    Sugiyama H
    Int J Hematol; 2001 Feb; 73(2):177-87. PubMed ID: 11372729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms' tumor suppressor WT1: approaches to gene function.
    Menke A; McInnes L; Hastie ND; Schedl A
    Kidney Int; 1998 Jun; 53(6):1512-8. PubMed ID: 9607183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Wilms' tumor gene (WT1) in human leukemias.
    Miwa H; Beran M; Saunders GF
    Leukemia; 1992 May; 6(5):405-9. PubMed ID: 1317488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Wilms' tumor suppressor gene WT1].
    Akiyama T
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1612-7. PubMed ID: 9279088
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic diagnosis of leukemia: diagnosis of relapse and complete remission, and prediction of leukemia onset].
    Sugiyama H
    Rinsho Byori; 2000 Feb; 48(2):155-61. PubMed ID: 10804819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
    Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
    EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
    Oka Y; Udaka K; Tsuboi A; Elisseeva OA; Ogawa H; Aozasa K; Kishimoto T; Sugiyama H
    J Immunol; 2000 Feb; 164(4):1873-80. PubMed ID: 10657636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels.
    Inoue K; Ogawa H; Yamagami T; Soma T; Tani Y; Tatekawa T; Oji Y; Tamaki H; Kyo T; Dohy H; Hiraoka A; Masaoka T; Kishimoto T; Sugiyama H
    Blood; 1996 Sep; 88(6):2267-78. PubMed ID: 8822948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination.
    Tsuboi A; Oka Y; Ogawa H; Elisseeva OA; Li H; Kawasaki K; Aozasa K; Kishimoto T; Udaka K; Sugiyama H
    J Clin Immunol; 2000 May; 20(3):195-202. PubMed ID: 10941827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells.
    Inoue K; Tamaki H; Ogawa H; Oka Y; Soma T; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Akiyama T; Kishimoto T; Sugiyama H
    Blood; 1998 Apr; 91(8):2969-76. PubMed ID: 9531608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA processing. Wilms' tumour--the splicing connection?
    Lamond AI
    Curr Biol; 1995 Aug; 5(8):862-5. PubMed ID: 7583142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
    Oka Y; Tsuboi A; Taguchi T; Osaki T; Kyo T; Nakajima H; Elisseeva OA; Oji Y; Kawakami M; Ikegame K; Hosen N; Yoshihara S; Wu F; Fujiki F; Murakami M; Masuda T; Nishida S; Shirakata T; Nakatsuka S; Sasaki A; Udaka K; Dohy H; Aozasa K; Noguchi S; Kawase I; Sugiyama H
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13885-90. PubMed ID: 15365188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.
    Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H
    Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.
    Sugiyama H
    Jpn J Clin Oncol; 2010 May; 40(5):377-87. PubMed ID: 20395243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.